Quick Takeaways
- John Snisarenko has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $339,606.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of John Snisarenko
- Location
- Alpharetta, GA
- Summary
- The estimated net worth of John Snisarenko is at least $339,606 dollars as of 18 Sep 2024. John Snisarenko is the Chief Commercial Officer of Oyster Point Pharma, Inc. and owns shares of Oyster Point Pharma, Inc. stock worth about $339.6K.
- Signature
- /s/ John Snisarenko
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow John Snisarenko and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Oyster Point Pharma, Inc. ($339,606).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of John Snisarenko
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| OYST | Oyster Point Pharma, Inc. | Chief Commercial Officer | $339,606 | 09 Jan 2022 | ||
| ALIM | ALIMERA SCIENCES INC | Director | $0 | 16 Sep 2024 |
Insider Transactions Reported by John Snisarenko:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.